Target Price | $325.89 |
Price | $297.56 |
Potential | 9.52% |
Number of Estimates | 27 |
27 Analysts have issued a price target JPMorgan Chase & Co. 2026 . The average JPMorgan Chase & Co. target price is $325.89. This is 9.52% higher than the current stock price. The highest price target is $367.50 23.50% , the lowest is $241.51 18.84% . | |
A rating was issued by 30 analysts: 19 Analysts recommend JPMorgan Chase & Co. to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the JPMorgan Chase & Co. stock has an average upside potential 2026 of 9.52% . Most analysts recommend the JPMorgan Chase & Co. stock at Purchase. |
24 Analysts have issued a sales forecast JPMorgan Chase & Co. 2025 . The average JPMorgan Chase & Co. sales estimate is $183b . This is 1.88% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $193b 7.70% , the lowest is $174b 2.91% .
This results in the following potential growth metrics:
2024 | $178b | 12.30% |
---|---|---|
2025 | $183b | 2.95% |
2026 | $188b | 2.78% |
2027 | $196b | 4.22% |
2028 | $189b | 3.70% |
2029 | $196b | 4.00% |
2030 | $203b | 3.70% |
2031 | $212b | 4.11% |
2032 | $221b | 4.26% |
29 JPMorgan Chase & Co. Analysts have issued a net profit forecast 2025. The average JPMorgan Chase & Co. net profit estimate is $53.8b . This is 5.02% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $57.2b 0.95% , the lowest is $49.1b 13.36% .
This results in the following potential growth metrics and future Net Margins:
2024 | $56.9b | 19.07% |
---|---|---|
2025 | $53.8b | 5.37% |
2026 | $56.0b | 4.08% |
2027 | $60.5b | 8.09% |
2028 | $60.2b | 0.54% |
2029 | $66.1b | 9.73% |
2030 | $71.6b | 8.45% |
2031 | $78.8b | 9.98% |
2032 | $78.8b | 0.00% |
2024 | 32.03% | 6.03% |
---|---|---|
2025 | 29.44% | 8.08% |
2026 | 29.81% | 1.26% |
2027 | 30.92% | 3.72% |
2028 | 31.93% | 3.27% |
2029 | 33.69% | 5.51% |
2030 | 35.23% | 4.57% |
2031 | 37.22% | 5.65% |
2032 | 35.70% | 4.08% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 19.75 | 19.77 |
21.69% | 0.10% | |
P/E | 15.05 | |
EV/Sales | 10.30 |
29 Analysts have issued a JPMorgan Chase & Co. forecast for earnings per share. The average JPMorgan Chase & Co. EPS is $19.77 . This is 3.42% lower than earnings per share in the financial year 2024. The highest EPS forecast is $21.01 2.64% , the lowest is $18.03 11.92% .
This results in the following potential growth metrics and future valuations:
2024 | $19.75 | 21.69% |
---|---|---|
2025 | $19.77 | 0.10% |
2026 | $20.57 | 4.05% |
2027 | $22.24 | 8.12% |
2028 | $22.12 | 0.54% |
2029 | $24.27 | 9.72% |
2030 | $26.32 | 8.45% |
2031 | $28.95 | 9.99% |
2032 | $28.95 | 0.00% |
Current | 14.54 | 18.76% |
---|---|---|
2025 | 15.05 | 3.53% |
2026 | 14.46 | 3.92% |
2027 | 13.38 | 7.47% |
2028 | 13.45 | 0.52% |
2029 | 12.26 | 8.85% |
2030 | 11.31 | 7.75% |
2031 | 10.28 | 9.11% |
2032 | 10.28 | 0.00% |
Based on analysts' sales estimates for 2025, the JPMorgan Chase & Co. stock is valued at an EV/Sales of 10.30 and an P/S ratio of 4.48 .
This results in the following potential growth metrics and future valuations:
Current | 10.49 | 94.62% |
---|---|---|
2025 | 10.30 | 1.84% |
2026 | 10.02 | 2.71% |
2027 | 9.61 | 4.05% |
2028 | 9.98 | 3.85% |
2029 | 9.60 | 3.85% |
2030 | 9.26 | 3.57% |
2031 | 8.89 | 3.95% |
2032 | 8.53 | 4.08% |
Current | 4.56 | 98.33% |
---|---|---|
2025 | 4.48 | 1.85% |
2026 | 4.35 | 2.71% |
2027 | 4.18 | 4.05% |
2028 | 4.34 | 3.85% |
2029 | 4.17 | 3.85% |
2030 | 4.02 | 3.56% |
2031 | 3.86 | 3.95% |
2032 | 3.71 | 4.08% |
JPMorgan Chase & Co....
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 15 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Oct 07 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Sep 30 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 29 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Sep 24 2025 |
Truist Securities |
Hold
➜
Hold
|
Unchanged | Sep 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 15 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 15 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Oct 07 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Sep 30 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 29 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Sep 24 2025 |
Unchanged
Truist Securities:
Hold
➜
Hold
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.